Addressing High-Volume Hemostasis with the Scalable Sysmex CN-9000 Solution
The modular system combines high-throughput analysis with a flexible footprint to enhance workflow efficiency in busy laboratories.
The modular system combines high-throughput analysis with a flexible footprint to enhance workflow efficiency in busy laboratories.
AI, new diagnostics, and shifting care delivery models are among the clinical laboratory predictions for 2026.
Ambry Genetics has completed its one millionth DNA/RNA genetic test, highlighting increased adoption of RNA-enhanced diagnostics for hereditary cancer and rare diseases, according to the company.
nRichDX and Hamilton have integrated the Revolution Plus Sample Prep System with the Microlab STAR platform, enabling automated extraction of cfDNA, cfRNA, cfTNA, and CTCs from sample volumes of 1 to 100 mL.
A new study found the assay detected immunotherapy response in advanced cancer patients a median of 23 days after treatment—over five months earlier than imaging.